Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041215
Filing Date
2017-06-21
Accepted
2017-06-21 17:01:00
Documents
1
Period of Report
2017-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3546
  Complete submission text file 0001209191-17-041215.txt   4943
Mailing Address C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA RM 5508 NEW YORK NY 21264957
Business Address
EVNIN ANTHONY B (Reporting) CIK: 0001239241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 17923374

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)